Current Report Filing (8-k)
May 04 2016 - 4:16PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K
CURRENT REPORT
Pursuant
to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (date of earliest event reported): May 4, 2016
DAVITA HEALTHCARE PARTNERS INC.
(Exact name of registrant as specified in its charter)
|
|
|
|
|
Delaware
|
|
1-14106
|
|
No. 51-0354549
|
(State or other jurisdiction
of incorporation)
|
|
(Commission File Number)
|
|
(IRS Employer
Identification No.)
|
2000 16
th
Street
Denver, CO 80202
(Address
of principal executive offices including Zip Code)
(303) 405-2100
(Registrants telephone number, including area code)
Not applicable
(Former
name or former address, if changed since last report)
Check the appropriate box below
if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 240.425)
|
¨
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
¨
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
¨
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 2.02 Results of Operations and Financial Condition.
On May 4, 2016, DaVita HealthCare Partners Inc. issued a press release announcing its financial results for the quarter ended
March 31, 2016. A copy of the press release is furnished as Exhibit 99.1 to this report.
The information contained in this Form 8-K
(including Exhibit 99.1 attached hereto) is being furnished and shall not be deemed to be filed for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the Exchange Act), or otherwise subject
to the liabilities of that section and shall not be incorporated by reference in any filing under the Securities Act of 1933, as amended or the Exchange Act, except as shall be expressly set forth by specific reference in such filing.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
|
|
|
Exhibit
Number
|
|
Description
|
|
|
99.1
|
|
Press Release dated May 4, 2016 announcing the registrants financial results for the quarter ended March 31, 2016.
|
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
|
|
|
|
|
|
|
DAVITA HEALTHCARE PARTNERS INC.
|
|
|
|
Date: May 4, 2016
|
|
By:
|
|
/s/ James K. Hilger
|
|
|
|
|
James K. Hilger
|
|
|
|
|
Chief Accounting Officer
|
EXHIBIT INDEX
|
|
|
Exhibit
Number
|
|
Description
|
|
|
99.1
|
|
Press Release dated May 4, 2016, announcing the registrants financial results for the quarter ended March 31, 2016.
|
DaVita (NYSE:DVA)
Historical Stock Chart
From Aug 2024 to Sep 2024
DaVita (NYSE:DVA)
Historical Stock Chart
From Sep 2023 to Sep 2024